Related references
Note: Only part of the references are listed.Totally Drug-Resistant Tuberculosis in India
Zarir F. Udwadia et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Risk of Tuberculosis Disease Among Persons With Diabetes Mellitus: A Prospective Cohort Study
Meghan A. Baker et al.
CLINICAL INFECTIOUS DISEASES (2012)
Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005
J. S. Cavanaugh et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis
K. Blondal et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2012)
Treatment outcomes for children with multidrug-resistant tuberculosis: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET INFECTIOUS DISEASES (2012)
The impact of diabetes on tuberculosis treatment outcomes: A systematic review
Meghan A. Baker et al.
BMC MEDICINE (2011)
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis
J. Lee et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2011)
Factors Associated with Anti-Tuberculosis Medication Adverse Effects: A Case-Control Study in Lima, Peru
Kocfa Chung-Delgado et al.
PLOS ONE (2011)
Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment
Sonya S. Shin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Recurrence after Treatment for Pulmonary Multidrug-Resistant Tuberculosis
Mercedes C. Becerra et al.
CLINICAL INFECTIOUS DISEASES (2010)
Risk Factors for MDR and XDR-TB in a Tertiary Referral Hospital in India
V. Balaji et al.
PLOS ONE (2010)
Follow-Up of Patients with Multidrug Resistant Tuberculosis Four Years after Standardized First-Line Drug Treatment
Guang Xue He et al.
PLOS ONE (2010)
Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects
R. J. Al-Attiyah et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Type 2 diabetes and multidrug-resistant tuberculosis
Susan P. Fisher-Hoch et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies
Christie Y. Jeon et al.
PLOS MEDICINE (2008)
Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, Peru
Jose G. Somocurcio et al.
THORAX (2007)
Nurses as providers of emotional support to patients with MDR-TB
K. Chalco et al.
INTERNATIONAL NURSING REVIEW (2006)
Programmes and principles in treatment of multidrug-resistant tuberculosis
JS Mukherjee et al.
LANCET (2004)
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
C Mitnick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients:: a national cohort study in Peru
PG Suárez et al.
LANCET (2002)
The treatment of multidrug-resistant tuberculosis in Turkey
K Tahaoglu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
